Abstract
The alerting reaction associated with the doctor’s visit or more in general with the situation of being in a medical environment causes important interference with blood pressure (BP) measurement in the clinical setting, possibly leading to misclassification of BP levels [1]. Indeed, more than 30 % of subjects who present an acute elevation of BP levels in the doctor’s office (white-coat effect, WCE) may be diagnosed as having white-coat hypertension (WCH, or isolated office hypertension, i.e., the condition characterized by persistently elevated office BP levels and normal ambulatory and/or home BP levels). In recognition of this, current hypertension guidelines have included the suspicion of WCH among the clinical indications for performing out-of-office BP monitoring [2, 3]. However, since performing ambulatory BP monitoring in all subjects who present with elevation in BP levels in the medical office is not always feasible, several studies have been conducted in the attempt to identify clinical and demographic factors that could help the practicing physician to suspect WCH and thus to reasonably proceed with performance ambulatory BP monitoring. However, no clear evidence has been so far provided regarding the clinical features that should be considered in order to raise this suspicion. The first pioneering studies implementing continuous intra-arterial BP recordings indicated that the magnitude of the WCE during a physician visit is largely variable among different subjects, which makes it hardly predictable in the individual patient [1]. Moreover, this interindividual variability in the magnitude of the WCE was not entirely explained by differences in clinical or demographic patients’characteristics (i.e., age, sex, 24-h BP levels) nor by the degree of spontaneous 24-h BP variability [1]. Inconclusive have also been the results of studies exploring the role of other potential predictors for WCE and WCH, such as the pressor response to physical and mental laboratory stress, psychobehavioral factors, or physical activity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mancia G, Bertinieri G, Grassi G, Parati G, Pomidossi G, Ferrari A et al (1983) Effects of blood-pressure measurement by the doctor on patient’s blood pressure and heart rate. Lancet 2(8352):695–698. Epub 1983/09/24
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M et al (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31(7):1281–1357. Epub 2013/07/03
O’Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G et al (2013) European society of hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 31(9):1731–1768. Epub 2013/09/14
Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH (1988) How common is white coat hypertension? JAMA 259(2):225–228. Epub 1988/01/08
Verdecchia P, Palatini P, Schillaci G, Mormino P, Porcellati C, Pessina AC (2001) Independent predictors of isolated clinic (‘white-coat’) hypertension. J Hypertens 19(6):1015–1020. Epub 2001/06/14
Dolan E, Stanton A, Atkins N, Den Hond E, Thijs L, McCormack P et al (2004) Determinants of white-coat hypertension. Blood Press Monit 9(6):307–309. Epub 2004/11/27
Parati G, Pomidossi G, Casadei R, Mancia G (1985) Lack of alerting reactions to intermittent cuff inflations during noninvasive blood pressure monitoring. Hypertension 7(4):597–601. Epub 1985/07/01
Lantelme P, Milon H, Vernet M, Gayet C (2000) Difference between office and ambulatory blood pressure or real white coat effect: does it matter in terms of prognosis? J Hypertens 18(4):383–389. Epub 2000/04/25
Parati G, Omboni S, Staessen J, Thijs L, Fagard R, Ulian L et al (1998) Limitations of the difference between clinic and daytime blood pressure as a surrogate measure of the ‘white-coat’ effect. Syst-Eur investigators. J Hypertens 16(1):23–29. Epub 1998/04/09
Parati G, Ulian L, Santucciu C, Omboni S, Mancia G (1998) Difference between clinic and daytime blood pressure is not a measure of the white coat effect. Hypertension 31(5):1185–1189. Epub 1998/05/12
Palatini P, Palomba D, Bertolo O, Minghetti R, Longo D, Sarlo M et al (2003) The white-coat effect is unrelated to the difference between clinic and daytime blood pressure and is associated with greater reactivity to public speaking. J Hypertens 21(3):545–553. Epub 2003/03/18
Leary AC, Donnan PT, MacDonald TM, Murphy MB (2002) The white-coat effect is associated with increased blood pressure reactivity to physical activity. Blood Press Monit 7(4):209–213. Epub 2002/08/29
Siegel WC, Blumenthal JA, Divine GW (1990) Physiological, psychological, and behavioral factors and white coat hypertension. Hypertension 16(2):140–146. Epub 1990/08/01
Owens P, Atkins N, O’Brien E (1999) Diagnosis of white coat hypertension by ambulatory blood pressure monitoring. Hypertension 34(2):267–272. Epub 1999/08/24
Myers MG, Valdivieso M, Kiss A (2009) Use of automated office blood pressure measurement to reduce the white coat response. J Hypertens 27(2):280–286. Epub 2009/01/22
Myers MG, Godwin M, Dawes M, Kiss A, Tobe SW, Kaczorowski J (2010) Measurement of blood pressure in the office: recognizing the problem and proposing the solution. Hypertension 55(2):195–200. Epub 2009/12/30
Mancia G, Parati G, Pomidossi G, Grassi G, Casadei R, Zanchetti A (1987) Alerting reaction and rise in blood pressure during measurement by physician and nurse. Hypertension 9(2):209–215. Epub 1987/02/01
Myers MG, Valdivieso M, Chessman M, Kiss A (2010) Can sphygmomanometers designed for self-measurement of blood pressure in the home be used in office practice? Blood Press Monit 15(6):300–304. Epub 2010/10/27
Watson RD, Lumb R, Young MA, Stallard TJ, Davies P, Littler WA (1987) Variation in cuff blood pressure in untreated outpatients with mild hypertension–implications for initiating antihypertensive treatment. J Hypertens 5(2):207–211. Epub 1987/04/01
Colloca L, Finniss D (2012) Nocebo effects, patient-clinician communication, and therapeutic outcomes. JAMA 307(6):567–568. Epub 2012/02/10
Myers MG, Meglis G, Polemidiotis G (1997) The impact of physician vs automated blood pressure readings on office-induced hypertension. J Hum Hypertens 11(8):491–493. Epub 1997/08/01
Gerin W, Ogedegbe G, Schwartz JE, Chaplin WF, Goyal T, Clemow L et al (2006) Assessment of the white-coat effect. J Hypertens 24(1):67–74. Epub 2005/12/07
Stergiou GS, Efstathiou SP, Alamara CV, Mastorantonakis SE, Roussias LG (2003) Home or self blood pressure measurement? What is the correct term? J Hypertens 21(12):2259–2264. Epub 2003/12/05
Parati G, Pomidossi G, Casadei R, Ravogli A, Groppelli A, Cesana B et al (1988) Comparison of the cardiovascular effects of different laboratory stressors and their relationship with blood pressure variability. J Hypertens 6(6):481–488. Epub 1988/06/01
Palatini P (1997) Exercise haemodynamics: field activities versus laboratory tests. Blood Press Monit 2(3):133–137. Epub 1997/06/01
Lantelme P, Milon H, Gharib C, Gayet C, Fortrat JO (1998) White coat effect and reactivity to stress: cardiovascular and autonomic nervous system responses. Hypertension 31(4):1021–1029. Epub 1998/04/16
Le Pailleur C, Montgermont P, Feder JM, Metzger JP, Vacheron A (2001) Talking effect and “white coat” effect in hypertensive patients: physical effort or emotional content? Behav Med 26(4):149–157. Epub 2001/06/21
Parati G, Pomidossi G, Ramirez A, Cesana B, Mancia G (1985) Variability of the haemodynamic responses to laboratory tests employed in assessment of neural cardiovascular regulation in man. Clin Sci (Lond) 69(5):533–540. Epub 1985/11/01
Munakata M, Hiraizumi T, Tomiie T, Saito Y, Ichii S, Nunokawa T et al (1998) Psychobehavioral factors involved in the isolated office hypertension: comparison with stress-induced hypertension. J Hypertens 16(4):419–422. Epub 1998/10/31
Khattar RS, Senior R, Lahiri A (1998) Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study. Circulation 98(18):1892–1897. Epub 1998/11/03
Staessen JA, O’Brien ET, Atkins N, Amery AK (1993) Short report: ambulatory blood pressure in normotensive compared with hypertensive subjects. The Ad-Hoc Working Group. J Hypertens 11(11):1289–1297. Epub 1993/11/01
Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Zampi I, Gattobigio R et al (1995) White coat hypertension and white coat effect. Similarities and differences. Am J Hypertens 8(8):790–798. Epub 1995/08/01
Bjorklund K, Lind L, Vessby B, Andren B, Lithell H (2002) Different metabolic predictors of white-coat and sustained hypertension over a 20-year follow-up period: a population-based study of elderly men. Circulation 106(1):63–68. Epub 2002/07/03
Gomez-Cerezo J, Rios Blanco JJ, Suarez Garcia I, Moreno Anaya P, Garcia Raya P, Vazquez-Munoz E et al (2002) Noninvasive study of endothelial function in white coat hypertension. Hypertension 40(3):304–309. Epub 2002/09/07
Pierdomenico SD, Cipollone F, Lapenna D, Bucci A, Cuccurullo F, Mezzetti A (2002) Endothelial function in sustained and white coat hypertension. Am J Hypertens 15(11):946–952. Epub 2002/11/21
de la Sierra A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P et al (2011) Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 57(5):898–902. Epub 2011/03/30
Oikawa T, Obara T, Ohkubo T, Kikuya M, Asayama K, Metoki H et al (2006) Characteristics of resistant hypertension determined by self-measured blood pressure at home and office blood pressure measurements: the J-HOME study. J Hypertens 24(9):1737–1743. Epub 2006/08/18
de la Sierra A, Banegas JR, Oliveras A, Gorostidi M, Segura J, de la Cruz JJ et al (2012) Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs. J Hypertens 30(6):1211–1216. Epub 2012/04/25
Parati G, Omboni S, Mancia G (1996) Difference between office and ambulatory blood pressure and response to antihypertensive treatment. J Hypertens 14(6):791–797. Epub 1996/06/01
Morimoto S, Takeda K, Oguni A, Kido H, Harada S, Moriguchi J et al (2001) Reduction of white coat effect by cilnidipine in essential hypertension. Am J Hypertens 14(10):1053–1057. Epub 2001/11/17
Parati G, Ulian L, Sampieri L, Palatini P, Villani A, Vanasia A et al (2000) Attenuation of the “white-coat effect” by antihypertensive treatment and regression of target organ damage. Hypertension 35(2):614–620. Epub 2000/02/19
Egan BM, Zhao Y, Axon RN, Brzezinski WA, Ferdinand KC (2011) Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation 124(9):1046–1058. Epub 2011/08/10
Brambilla G, Bombelli M, Seravalle G, Cifkova R, Laurent S, Narkiewicz K et al (2013) Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study. J Hypertens 31(10):2018–2024. Epub 2013/07/11
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al (2003) Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42(6):1206–1252. Epub 2003/12/06
O’Brien E (2008) Ambulatory blood pressure measurement: the case for implementation in primary care. Hypertension 51(6):1435–1441. Epub 2008/03/26
Saito S, Asayama K, Ohkubo T, Kikuya M, Metoki H, Obara T et al (2004) The second progress report on the Hypertension Objective treatment based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) study. Blood Press Monit 9(5):243–247. Epub 2004/10/09
Parati G, Mancia G (2003) White coat effect: semantics, assessment and pathophysiological implications. J Hypertens 21(3):481–486. Epub 2003/03/18
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Parati, G., Ochoa, J.E., Lombardi, C., Bilo, G. (2015). Predictive Factors for White-Coat Hypertension. In: White Coat Hypertension. Springer, Cham. https://doi.org/10.1007/978-3-319-07410-8_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-07410-8_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-07409-2
Online ISBN: 978-3-319-07410-8
eBook Packages: MedicineMedicine (R0)